Isabel Lastres‐Becker

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease

Isabel Lastres‐Becker, Francisco Molina‐Holgado, J.A. Ramos et al. · Neurobiology of Disease · 2005 · 403 citations · Full text

Cannabis Use, Psychoactive Drug, Medicine +11

Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation

Antonio Cuadrado, Zaira Martín‐Moldes, Jianping Ye et al. · Journal of Biological Chemistry · 2014 · 307 citations · Full text

Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease

Isabel Lastres‐Becker, Ángel J. García‐Yagüe, Robert H. Scannevin et al. · Antioxidants and Redox Signaling · 2016 · 263 citations · Full text

α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease

Isabel Lastres‐Becker, Ayşe Ulusoy, Nadia G. Innamorato et al. · Human Molecular Genetics · 2012 · 257 citations · Full text

Synaptic Transmission, Cell Death, α-Synuclein Expression +25

Anandamide, but not 2‐arachidonoylglycerol, accumulates during <i>in vivo</i> neurodegeneration

Henrik H. Hansen, Patricia C. Schmid, Petra Bittigau et al. · Journal of Neurochemistry · 2001 · 214 citations